Polymorphisms in integrin genes and lymphoma risk

Min Shen, Tongzhang Zheng, Qing Lan, Yawei Zhang, Howard D. Hosgood, Shelia H. Zahm, Theodore R. Holford, Brian Leaderer, Meredith Yeager, Jeff Yuenger, Stephen Chanock, Nathaniel Rothman

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Immune deficiency is one of the best characterized and strongest known risk factors for non-Hodgkin lymphoma (NHL). We studied the association between single nucleotide polymorphisms (SNPs) in integrin genes that are important components in human innate immunity and the risk of NHL in a population-based case-control study of women in Connecticut, USA. A total of 373 tag SNPs in 33 gene regions were included in the analysis of 448 cases and 525 controls. The ADAM19 rs11466782 SNP was associated with an increased risk of lymphoma (OR, 1.73; 95% CI, 1.28-2.35; Padditive=0.0004), and the ICAM3 rs2304240 (OR, 0.67; 95% CI, 0.52-0.86; Padditive=0.002) and the PTGDR rs708486 SNPs (OR, 0.75; 95% CI, 0.63-0.90; Padditive=0.002) were associated with reduced risk of lymphoma. Two gene regions (ADAM19 (P=0.009) and ICAM3 (P=0.009)) displayed global associations with lymphoma risk at the P<0.01 level. While our results suggest that genetic polymorphisms in integrin genes may play a role in the genesis of lymphoma in women, they should be viewed as exploratory until they are replicated in additional populations.

Original languageEnglish (US)
Pages (from-to)968-970
Number of pages3
JournalLeukemia Research
Volume35
Issue number7
DOIs
StatePublished - Jul 2011
Externally publishedYes

Fingerprint

Integrins
Single Nucleotide Polymorphism
Lymphoma
Non-Hodgkin's Lymphoma
Genes
Gene Components
Genetic Polymorphisms
Innate Immunity
Population
Case-Control Studies

Keywords

  • Innate immunity
  • Integrin
  • Lymphoma
  • Single nucleotide polymorphism

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Shen, M., Zheng, T., Lan, Q., Zhang, Y., Hosgood, H. D., Zahm, S. H., ... Rothman, N. (2011). Polymorphisms in integrin genes and lymphoma risk. Leukemia Research, 35(7), 968-970. https://doi.org/10.1016/j.leukres.2010.12.012

Polymorphisms in integrin genes and lymphoma risk. / Shen, Min; Zheng, Tongzhang; Lan, Qing; Zhang, Yawei; Hosgood, Howard D.; Zahm, Shelia H.; Holford, Theodore R.; Leaderer, Brian; Yeager, Meredith; Yuenger, Jeff; Chanock, Stephen; Rothman, Nathaniel.

In: Leukemia Research, Vol. 35, No. 7, 07.2011, p. 968-970.

Research output: Contribution to journalArticle

Shen, M, Zheng, T, Lan, Q, Zhang, Y, Hosgood, HD, Zahm, SH, Holford, TR, Leaderer, B, Yeager, M, Yuenger, J, Chanock, S & Rothman, N 2011, 'Polymorphisms in integrin genes and lymphoma risk', Leukemia Research, vol. 35, no. 7, pp. 968-970. https://doi.org/10.1016/j.leukres.2010.12.012
Shen, Min ; Zheng, Tongzhang ; Lan, Qing ; Zhang, Yawei ; Hosgood, Howard D. ; Zahm, Shelia H. ; Holford, Theodore R. ; Leaderer, Brian ; Yeager, Meredith ; Yuenger, Jeff ; Chanock, Stephen ; Rothman, Nathaniel. / Polymorphisms in integrin genes and lymphoma risk. In: Leukemia Research. 2011 ; Vol. 35, No. 7. pp. 968-970.
@article{531f51473d4d476784bf565b06d22228,
title = "Polymorphisms in integrin genes and lymphoma risk",
abstract = "Immune deficiency is one of the best characterized and strongest known risk factors for non-Hodgkin lymphoma (NHL). We studied the association between single nucleotide polymorphisms (SNPs) in integrin genes that are important components in human innate immunity and the risk of NHL in a population-based case-control study of women in Connecticut, USA. A total of 373 tag SNPs in 33 gene regions were included in the analysis of 448 cases and 525 controls. The ADAM19 rs11466782 SNP was associated with an increased risk of lymphoma (OR, 1.73; 95{\%} CI, 1.28-2.35; Padditive=0.0004), and the ICAM3 rs2304240 (OR, 0.67; 95{\%} CI, 0.52-0.86; Padditive=0.002) and the PTGDR rs708486 SNPs (OR, 0.75; 95{\%} CI, 0.63-0.90; Padditive=0.002) were associated with reduced risk of lymphoma. Two gene regions (ADAM19 (P=0.009) and ICAM3 (P=0.009)) displayed global associations with lymphoma risk at the P<0.01 level. While our results suggest that genetic polymorphisms in integrin genes may play a role in the genesis of lymphoma in women, they should be viewed as exploratory until they are replicated in additional populations.",
keywords = "Innate immunity, Integrin, Lymphoma, Single nucleotide polymorphism",
author = "Min Shen and Tongzhang Zheng and Qing Lan and Yawei Zhang and Hosgood, {Howard D.} and Zahm, {Shelia H.} and Holford, {Theodore R.} and Brian Leaderer and Meredith Yeager and Jeff Yuenger and Stephen Chanock and Nathaniel Rothman",
year = "2011",
month = "7",
doi = "10.1016/j.leukres.2010.12.012",
language = "English (US)",
volume = "35",
pages = "968--970",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Elsevier Limited",
number = "7",

}

TY - JOUR

T1 - Polymorphisms in integrin genes and lymphoma risk

AU - Shen, Min

AU - Zheng, Tongzhang

AU - Lan, Qing

AU - Zhang, Yawei

AU - Hosgood, Howard D.

AU - Zahm, Shelia H.

AU - Holford, Theodore R.

AU - Leaderer, Brian

AU - Yeager, Meredith

AU - Yuenger, Jeff

AU - Chanock, Stephen

AU - Rothman, Nathaniel

PY - 2011/7

Y1 - 2011/7

N2 - Immune deficiency is one of the best characterized and strongest known risk factors for non-Hodgkin lymphoma (NHL). We studied the association between single nucleotide polymorphisms (SNPs) in integrin genes that are important components in human innate immunity and the risk of NHL in a population-based case-control study of women in Connecticut, USA. A total of 373 tag SNPs in 33 gene regions were included in the analysis of 448 cases and 525 controls. The ADAM19 rs11466782 SNP was associated with an increased risk of lymphoma (OR, 1.73; 95% CI, 1.28-2.35; Padditive=0.0004), and the ICAM3 rs2304240 (OR, 0.67; 95% CI, 0.52-0.86; Padditive=0.002) and the PTGDR rs708486 SNPs (OR, 0.75; 95% CI, 0.63-0.90; Padditive=0.002) were associated with reduced risk of lymphoma. Two gene regions (ADAM19 (P=0.009) and ICAM3 (P=0.009)) displayed global associations with lymphoma risk at the P<0.01 level. While our results suggest that genetic polymorphisms in integrin genes may play a role in the genesis of lymphoma in women, they should be viewed as exploratory until they are replicated in additional populations.

AB - Immune deficiency is one of the best characterized and strongest known risk factors for non-Hodgkin lymphoma (NHL). We studied the association between single nucleotide polymorphisms (SNPs) in integrin genes that are important components in human innate immunity and the risk of NHL in a population-based case-control study of women in Connecticut, USA. A total of 373 tag SNPs in 33 gene regions were included in the analysis of 448 cases and 525 controls. The ADAM19 rs11466782 SNP was associated with an increased risk of lymphoma (OR, 1.73; 95% CI, 1.28-2.35; Padditive=0.0004), and the ICAM3 rs2304240 (OR, 0.67; 95% CI, 0.52-0.86; Padditive=0.002) and the PTGDR rs708486 SNPs (OR, 0.75; 95% CI, 0.63-0.90; Padditive=0.002) were associated with reduced risk of lymphoma. Two gene regions (ADAM19 (P=0.009) and ICAM3 (P=0.009)) displayed global associations with lymphoma risk at the P<0.01 level. While our results suggest that genetic polymorphisms in integrin genes may play a role in the genesis of lymphoma in women, they should be viewed as exploratory until they are replicated in additional populations.

KW - Innate immunity

KW - Integrin

KW - Lymphoma

KW - Single nucleotide polymorphism

UR - http://www.scopus.com/inward/record.url?scp=79958739572&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958739572&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2010.12.012

DO - 10.1016/j.leukres.2010.12.012

M3 - Article

C2 - 21239057

AN - SCOPUS:79958739572

VL - 35

SP - 968

EP - 970

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

IS - 7

ER -